Newsletter

Subscribe to our newsletter to stay informed.

Newsletter Overlay EN
Salutation
* Mandatory fields
Policy
Member Login Media Newsletter
ENFRDE
  2. Über uns
  3. Vorstand

Board

The Interpharma Board determines the strategic direction of the association and represents the interests of research-based pharmaceutical companies in Switzerland.

Portrait of Jörg-Michael Rupp, President of Interpharma (Roche)

Jörg-Michael Rupp 1

President

Director Pharma International – Roche

Portrait of Julian Bertschinger, Vice-President of Interpharma (Johnson & Johnson)

Julian Bertschinger 1

Vice-President

Head EMEA External Scientific Innovation – Johnson & Johnson

Portrait of Myriam DeLeone, Vice-President of Interpharma (Amgen)

Myriam DeLeone 1

Vice-President

General Manager Switzerland – Amgen

Portrait of Iris Zemzoum, Vice-President of Interpharma (Novartis)

Iris Zemzoum 1, 2

Vice-President

President Region Europe – Novartis

Portrait of René P. Buholzer, CEO of Interpharma

René P. Buholzer

Delegate of the Board

Interpharma

Portrait of Jérome Garcin, member of the Interpharma Board (Bristol Myers Squibb)

Jérome Garcin

General Manager for Switzerland and Austria – Bristol Myers Squibb

Portrait of Thorsten Hein, member of the Interpharma Board (Bayer)

Thorsten Hein

Country Division Head, Pharmaceuticals – Bayer

Portrait of Bairbre Hickie, member of the Interpharma Board (Takeda)

Bairbre Hickie 1, 2

General Manager Switzerland – Takeda

Portrait of Rea Lal, member of the Interpharma Board (Pfizer)

Rea Lal

Country Lead of Pfizer Switzerland – Pfizer

Portrait of Annette Luther, member of the Interpharma Board (Roche)

Annette Luther 2

Head External Affairs Switzerland – Roche

Portrait of Lauren McNamer, member of the Interpharma Board (Eli Lilly)

Lauren McNamer

General Manager of Lilly Switzerland – Eli Lilly

Portrait of Florian Saur, member of the Interpharma Board (AstraZeneca)

Florian Saur

Country President Switzerland – AstraZeneca

Portrait of Patrick Schuler, member of the Interpharma Board (Johnson & Johnson Innovative Medicine)

Patrick Schuler 2

Managing Director – Johnson & Johnson Innovative Medicine

Portrait of David Traub, member of the Interpharma Board (Novartis)

David Traub

Managing Director Pharma Switzerland – Novartis

Portrait of Anne Mette Wiis Vogelsang, member of the Interpharma Board (Novo Nordisk)

Anne Mette Wiis Vogelsang 2

CVP and General Manager Switzerland – Novo Nordisk

Legend:

1 Member of the Nomination and Membership Committee

2 Member of the Finance Board Committee